华西口腔医学杂志

• 基础研究 • 上一篇    下一篇

平阳霉素-活性炭纳米微粒对口腔鳞癌细胞系Tca8113和BcaCD885细胞体外的杀伤作用

孙明磊1 王昌美2 温玉明2   

  1. 1.郑州大学第一附属医院口腔颌面外科, 河南郑州450052;2.四川大学华西口腔医院口腔颌面外科, 四川成都610041
  • 收稿日期:2010-06-25 修回日期:2010-06-25 出版日期:2010-06-20 发布日期:2010-06-20
  • 通讯作者: 温玉明,Tel: 028-85501488
  • 作者简介:孙明磊(1973—),男,河南人,副主任医师,博士
  • 基金资助:

    卫生部科学研究基金资助项目(98-1-221)

Anticancer effects of Pingyangmycin-activated carbon nanoparticles against human oral squamous carcinoma Tca8113 and BcaCD885 cell lines in vitro

SUN Ming-lei1, WANG Chang-mei2, WEN Yu-ming2   

  1. 1. Dept. of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China; 2. Dept. of Oral and Maxillofacial Surgery, West China College of Stomatology, Sichuan University, Chengdu 610041, China
  • Received:2010-06-25 Revised:2010-06-25 Online:2010-06-20 Published:2010-06-20
  • Contact: WEN Yu-ming,Tel: 028-85501488

摘要:

目的探讨平阳霉素-活性炭纳米微粒(PYM-CH-NP)对人舌鳞癌细胞系Tca8113和颊鳞癌细胞系Bca-CD885的药物敏感性。方法采用甲基噻唑基四唑(MTT)法检测不同剂量的PYM-CH-NP和平阳霉素(PYM)在7个时间点(1~7 d)对Tca8113和BcaCD885的杀伤效应,计算各时间点2种剂型的半数抑癌率浓度值(IC50)、抑癌率和药物抗肿瘤作用强度的相对值(RAA),选择药物作用后第5天观察量效关系。结果PYM-CH-NP和PYM对Tca8113和BcaCD885均有较强的抑癌作用,其抗癌效应与药物浓度和作用时间相关。结论改型后的PYM-CH-NP保留了PYM的抗癌活性,且具有缓释性,作用于肿瘤时可以维持周围有效的浓度和作用时间,有效地杀伤肿瘤细胞。

关键词: 活性炭, 纳米微粒, 平阳霉素, 口腔肿瘤, 缓释作用

Abstract:

Objective The cytotoxic effects of a new formulation of Pingyangmycin-activated carbon nanoparticles(PYM-CH-NP) on two human oral squamous cell carcinoma Tca8113 and BcaCD885 cell lines were studied in vitro. Methods The inhibitory effects of PYM-CH-NP and Pingyangmycin(PYM) were evaluated by methyl thiazolyl tetrazolium(MTT) assay at 1 -7 days. The 50% inhibition concentration values(IC50) and relative anti tumor activity(RAA) of PYM-CH-NP and PYM against Tca8113 and BcaCD885 with different drug concentration were evaluated. The time-dependent cytotoxic effects of PYM-CH-NP and PYM were during 1-5 days, so the doseeffect relationship was investigated at 5th day. Results Both PYM-CH-NP and PYM had high anticancer effects on Tca8113 and BcaCD885, and the cytotoxic effects were dose -dependent and time -dependent. Conclusion The activated carbon nanoparticles(CH-NP) may serve as a new drug delivery carrier of PYM. The new formulation PYM-CH-NP could slow down drug release, prolonged the drug concentration and its acting time, so more effective anticancer efficacy could be achieved.

Key words: activated carbon, nanoparticle, Pingyangmycin, oral cancer, sustained release